All About The Latest Updates

“It has the potential to trigger most cancers” advises in opposition to taking weight reduction capsules by NAFDAC

"It has the potential to cause cancer" advises against taking weight loss capsules by NAFDAC

The Nationwide Company for Meals and Drug Administration and Management (NAFDAC) has warned Nigerians in opposition to utilizing the drug – Weight Speedy Loss Capsule.

This was in an alert quantity 049/2022, signed by NAFDAC Director Common, Prof. Mojisola Adeyeye, despatched to Information Company of Nigeria (NAN) on Sunday, January 22 in Abuja.

Adeyeye mentioned the drug had the potential to trigger most cancers.

The NAFDAC boss added that the results of a laboratory evaluation confirmed that the drug, manufactured by Ingi Oman, incorporates a banned substance “phenolphthalein”, which the US Meals and Drug Administration has acknowledged as harmful.

She added that the capsule, marketed as “the simplest weight reduction complement” and bought by way of social media platforms like Instagram, additionally incorporates microbial progress above allowable limits.

She mentioned, “Phenolphthalein has been proven to be poisonous to genes, as it might probably trigger DNA harm or mutations. Research have additionally proven its potential carcinogenic dangers.

“NAFDAC urges customers to cease buying and utilizing the product.

“Members of the general public in possession of the product ought to cease utilizing or promoting it and submit the inventory to the closest NAFDAC workplace.”

Adeyeye inspired healthcare professionals and customers to report any hostile reactions skilled whereas utilizing the product to the closest NAFDAC workplace.

Shoppers are additionally suggested to report hostile reactions through [email protected] or Digital Reporting Platforms obtainable at

The chief govt urged the general public to additionally report any incidents concerning using the drug through the Med-safety app, downloadable from the android and IOS shops.

Leave a Reply

Your email address will not be published. Required fields are marked *